SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-059043
Filing Date
2015-10-13
Accepted
2015-10-13 07:53:41
Documents
1
Period of Report
2015-10-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v422070_4.html 4  
1 OWNERSHIP DOCUMENT v422070_4.xml 4 3385
  Complete submission text file 0001144204-15-059043.txt   4889
Mailing Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016 646-440-9310
IMMUNE PHARMACEUTICALS INC (Issuer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMMUNE PHARMACEUTICALS INC. 777 OLD SAW MILL RIVER RD. TARRYTOWN NY 10591
Business Address
Teper Daniel Gedeon (Reporting) CIK: 0001584822 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36602 | Film No.: 151154604